<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Medical Laboratory Science and Pathology</title>
<link href="https://repository.ju.edu.et//handle/123456789/180" rel="alternate"/>
<subtitle/>
<id>https://repository.ju.edu.et//handle/123456789/180</id>
<updated>2026-04-17T11:23:40Z</updated>
<dc:date>2026-04-17T11:23:40Z</dc:date>
<entry>
<title>Genomic diversity and antimicrobial resistance profiles of Shigella  species in under-five children with acute diarrhea in Addis Ababa, Ethiopia</title>
<link href="https://repository.ju.edu.et//handle/123456789/10171" rel="alternate"/>
<author>
<name>Basha Ayele</name>
</author>
<author>
<name>Getenet Beyene</name>
</author>
<author>
<name>Zeleke Mekonnen</name>
</author>
<id>https://repository.ju.edu.et//handle/123456789/10171</id>
<updated>2026-03-03T07:14:45Z</updated>
<published>2026-01-11T00:00:00Z</published>
<summary type="text">Genomic diversity and antimicrobial resistance profiles of Shigella  species in under-five children with acute diarrhea in Addis Ababa, Ethiopia
Basha Ayele; Getenet Beyene; Zeleke Mekonnen
Background: Shigella species exhibit considerable genetic diversity, reflecting distinct &#13;
genomic traits and epidemiological trends. In Ethiopia, infections caused by Shigella &#13;
species, along with rising antimicrobial resistance (AMR), pose a major public health &#13;
threat, especially among children under five. To our knowledge, there are few studies on &#13;
the genetic diversity and antimicrobial susceptibility of Shigella species in this vulnerable &#13;
age group. Figuring this out could help treat cases better and control outbreaks more &#13;
effectively.    &#13;
Objective: This study aimed to characterize Shigella species' genomic diversity and AMR &#13;
profiles in under five children with acute diarrhea in Addis Ababa, Ethiopia. &#13;
Methods: Between June 2021 and April 2022, we conducted a cross-sectional study. &#13;
Freshly passed stool specimens were collected and transported in Cary Blair media to the &#13;
Ethiopian Public Health Institute (EPHI) laboratory for Shigella isolation and identification &#13;
using standard bacteriological methods. Serogrouping was performed using polyvalent &#13;
antisera, and antimicrobial susceptibility testing (AST) was conducted using the disk &#13;
diffusion method. Additionally, a systematic review and meta-analysis were conducted to &#13;
assess the prevalence and AMR patterns of Shigella species in East Africa. Molecular &#13;
characterization was performed using whole-genome sequencing (WGS) analysis. &#13;
Sequencing was conducted using the Illumina NextSeq550 (Illumina, Singapore) with a &#13;
300-cycle kit, generating paired-end reads of 149bp. Raw reads were quality-filtered and &#13;
trimmed to a minimum length of 50 bp before being taxonomically classified using &#13;
MiniKraken version 1. The whole genome data were aligned with Antibiotic Resistance &#13;
Gene (ARG) sequences from the Comprehensive Antibiotic Resistance Database (CARD) &#13;
using the Resistance Gene Identifier (RGI). Plasmid analysis was performed using the &#13;
Mykrobe PlasmidFinder tool. Additionally, AMR and virulence genes were screened using &#13;
the Centre for Genomic Epidemiology (CGE) web-based platform. Data were analyzed &#13;
using descriptive statistical tools. The association of independent and dependent variables &#13;
was evaluated with logistic regression. A P-value &lt; 0.05 was considered statistically &#13;
significant. &#13;
Results: Among the 534 stool-cultured specimens in the prospective study, 47 (8.8%) were &#13;
positive for Shigella species. Of these, 31 were serologically identified as S. sonnei and 16 &#13;
as S. flexneri. Of 37 isolates analyzed by WGS, all 28 S. sonnei strains identified &#13;
xiii &#13;
serologically were confirmed as S. sonnei. However, all nine isolates initially identified as &#13;
S. flexneri were found to be E. coli O37:H10. The phylogenetic tree showed that both  S. &#13;
sonnei and E. coli O37:H10 isolates had multiple evolutionary origins, suggesting that their &#13;
phenotypic features evolved convergently. Plasmids Col156 and Col (BS512) were &#13;
identified in all S. sonnei isolates, while IncFII and Col (MG828) plasmids were found only &#13;
in one isolate. In contrast to S. sonnei, the most common plasmid type in E. coli O37:H10 &#13;
isolates was IncFII, and virulence genes such as gad were frequently detected. &#13;
Discrepancies were observed between phenotypic and genotypic AMR results. The &#13;
systematic review estimated the pooled prevalence of Shigella species in East Africa was &#13;
6.2%. Despite variations in study sites and periods, the meta-analysis study further revealed &#13;
an increased rate of resistance of Shigella species to tetracycline, ampicillin, amoxicillin, &#13;
chloramphenicol, and co-trimoxazole. In the prospective study, AST showed that 100, 93.6, &#13;
80.9, 72.3, and 57.5% were sensitive to norfloxacin, nalidixic acid, ciprofloxacin, &#13;
gentamicin, and cefoxitin, respectively. However, 100% of the isolates were resistant to &#13;
amoxicillin. All isolates were resistant to three or more antimicrobials that exhibited &#13;
multidrug resistance (MDR). None of the risk factors assessed showed a statistically &#13;
significant association with Shigella infection. All S. sonnei isolates in our study contained &#13;
genes encoding blaEC-8 and blaZEG-1. About 60.7% of the isolates were phenotypically &#13;
sensitive to cefoxitin among the blaEC-8 genes detected in the genotyping analysis, &#13;
whereas all isolates were completely resistant to amoxicillin phenotypically. The study also &#13;
identified genes that conferred resistance to trimethoprim (dfrA1). Extended-spectrum beta&#13;
lactamase (ESBL) blaEC-15 for cephalosporins, blaMIX-2, and blaMIX-6 for penicillins &#13;
were detected in E. coli O37:H10. All E. coli O37:H10 isolates possessed a gene associated &#13;
with trimethoprim resistance, and eight E. coli O37:H10 isolates exhibited consistent &#13;
results for trimethoprim when comparing phenotype and genotype. The dominant AMR &#13;
mechanism among the identified ARGs was antibiotic efflux, followed by antibiotic target &#13;
alteration.  &#13;
Conclusion: There was no significant heterogeneity among East African studies, the &#13;
majority of which were conducted in Ethiopia. Both the systematic review and the &#13;
prospective phenotypic study revealed alarmingly increased levels of AMR to commonly &#13;
administered antibiotics. The genotyping study revealed that the most prevalent resistant &#13;
genes were associated with beta-lactam and trimethoprim drugs. The IncFII plasmid, which &#13;
primarily encodes ESBL, was more frequently identified in E. coli O37:H10 isolates than &#13;
xiv &#13;
in  S. sonnei. The study also highlighted a significant discrepancy between phenotypic and &#13;
genotypic drug resistance, as well as variations in serotypes and phylogenetic relationships &#13;
with global isolates.   &#13;
Recommendation: The study highlighted significant discrepancies between phenotypic &#13;
and genotypic results. Molecular studies integrating WGS for AMR determination and &#13;
strain identification into active surveillance could enhance monitoring of AMR spread &#13;
and detection of potential emerging variations. Therefore, public health and clinical &#13;
laboratories in Ethiopia should implement WGS to address inconsistencies in &#13;
conventional analyses, enhance treatment efficacy, and inform targeted interventions.
</summary>
<dc:date>2026-01-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>Bionomics, Insecticide Susceptibility and Characterization of Mid-Gut Micro biota In Anopheles Mosquitoes in Ethiopia</title>
<link href="https://repository.ju.edu.et//handle/123456789/10169" rel="alternate"/>
<author>
<name>Delelegn Woyessa Beddanie</name>
</author>
<author>
<name>Delenasaw Yewhalaw</name>
</author>
<id>https://repository.ju.edu.et//handle/123456789/10169</id>
<updated>2026-03-03T06:51:26Z</updated>
<published>2026-01-06T00:00:00Z</published>
<summary type="text">Bionomics, Insecticide Susceptibility and Characterization of Mid-Gut Micro biota In Anopheles Mosquitoes in Ethiopia
Delelegn Woyessa Beddanie; Delenasaw Yewhalaw
Background: This PhD dissertation explores the complex ecology of malaria vectors in Ethiopia, &#13;
where malaria transmission patterns remain spatially heterogeneous and shaped by the interplay of &#13;
diverse Anopheles mosquito species with distinct ecological, behavioural, and physiological &#13;
characteristics, and human interventions.Vector control efforts have been challenged by gaps in &#13;
knowledge regarding species composition, seasonal dynamics, insecticide resistance, infection &#13;
rates, and microbiota profiles.  &#13;
Objective: This dissertation aimed to characterize the bionomics, insecticide susceptibility, &#13;
infection rates, blood meal sources, and midgut microbiota diversity of key Anopheles species &#13;
vectors across multiple eco-epidemiological settings in Ethiopia.  &#13;
Methods: Data for the overall PhD research were collected between June 2018 and February 2023 &#13;
across three sites: Lare in Nuwer Zone (Gambella), Asendabo in Jimma Zone (Oromia), and Batu in &#13;
East Shewa Zone (Oromia). Adult Anopheles mosquitoes were sampled using CDC light traps, &#13;
human landing catches, and pyrethrum spray catches, while larvae were sampled by dipping from &#13;
breeding sites. Species identification was performed via morphological keys and species-specific &#13;
PCR. Plasmodium infection rates were assessed using sporozoite infection rates (SRs), &#13;
circumsporozoite proteins (CSP-ELISA) and TaqMan qPCR. Insecticide susceptibility was &#13;
determined using WHO standard bioassays and molecular screening for resistance markers (kdr &#13;
L1014F/S, ace-1 N485I, CYP6P9a). Midgut microbiota were isolated from aseptically dissected &#13;
mosquitoes and characterized using culture-based techniques and biochemical assays. &#13;
Results: A total of over 14,800 Anopheles mosquitoes, representing four species: An. arabiensis, &#13;
An. pharoensis, An. coustani, and An. funestus were collected. Anopheles coustani was the most &#13;
abundant species, accounting for more than 40% of the total collection and 42% in Lare.  Anopheles &#13;
pharoensis was the next most common, while An. arabiensis was dominant species in Asendabo &#13;
and Batu. Seasonal abundance peaked between June and November, except for An. funestus, which &#13;
was more prevalent during post malaria peak months in the dry season. All An.gambiae s.l. were &#13;
confirmed as An. arabiensis via PCR while more than 90% An. funestus s.l. from Lare were all &#13;
confirmed as An. funestus s.s. Despite the absence of insecticide resistance mutations (CYP6P9a, &#13;
kdr L1014F/S, ace-1 N485I) in An. funestus, phenotypic resistance to pyrethroids and &#13;
organochlorines was widespread in An. arabiensis, An. pharoensis, and An. coustani. Plasmodium&#13;
infected mosquitoes were identified across multiple species including, An. funestus, An. arabiensis, &#13;
An. coustani, and An. pharoensis, with An. funestus showing the highest entomological inoculation &#13;
IV &#13;
rate (10.52 bites/person/month), positive for both Plasmodium falciparum and P. vivax. Blood meal &#13;
analysis confirmed zoophilic tendencies and mixed feeding behaviour with spatio-temporal and &#13;
species-specific variation. Midgut microbiota analyses revealed 659 bacterial and five fungal &#13;
isolates from 129 mosquitoes across four species. Eleven bacterial genera were identified with &#13;
Staphylococcus, Klebsiella, Proteus, and Bacillus dominating. Microbial composition and &#13;
colonization intensity varied by species, site, life stage, and insecticide exposure status. &#13;
Remarkably, An. arabiensis survivors of DDT and permethrin exposure (from Batu) harbored &#13;
higher microbial loads compared to susceptible counterparts, possibly suggesting potential &#13;
microbiota-mediated resistance mechanisms. &#13;
Conclusions:  &#13;
This work highlights complex spatiotemporal patterns in Anopheles species composition, &#13;
insecticide resistance, infection rates, host choices, and midgut microbiota diversity across regions &#13;
in Ethiopia. The dry-season persistence and infection potential of An. funestus, along with the &#13;
widespread distribution and insecticide resistance observed in secondary and suspected vectors like &#13;
An. pharoensis and An. coustani in addition to the primary vector underscore the urgent need for &#13;
expanded and targeted vector surveillance. Moreover, the association between microbiota diversity &#13;
and insecticide resistance may offer new insights into vector competence and suggest potential for &#13;
microbiome-targeted interventions to complement existing malaria control strategies. Sustained &#13;
integrative entomological and microbiological monitoring is crucial for adaptive and effective &#13;
vector control in Ethiopia.
</summary>
<dc:date>2026-01-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Prevalence and Determinants of Erectile Dysfunction among Diabetic Patients Attending To Selected Governmental Hospitals, Guragezone, Southern Ethiopia</title>
<link href="https://repository.ju.edu.et//handle/123456789/10159" rel="alternate"/>
<author>
<name>Seid Abrar</name>
</author>
<author>
<name>Aklilu Getachew</name>
</author>
<author>
<name>Shiferaw Bekele</name>
</author>
<id>https://repository.ju.edu.et//handle/123456789/10159</id>
<updated>2026-02-27T12:38:31Z</updated>
<published>2021-03-06T00:00:00Z</published>
<summary type="text">Prevalence and Determinants of Erectile Dysfunction among Diabetic Patients Attending To Selected Governmental Hospitals, Guragezone, Southern Ethiopia
Seid Abrar; Aklilu Getachew; Shiferaw Bekele
Background:- Diabetes is an established risk factor for erectile dysfunction in men, as a&#13;
threefold increased risk of erectile dysfunction was documented in diabetic men. Erectile&#13;
dysfunction is more prevalent in men with Diabetes mellitus (35-90%), as compared with&#13;
nondiabetic men. Men experiencing this sexual disorder have demonstrated severe deficits in&#13;
their overall quality of life.&#13;
Objective:- To determine the prevalence and determinants of erectile dysfunction among&#13;
diabetic patients attending selected governmental hospitals, Gurage Zone, Southern Ethiopia&#13;
from September 1 to December 30, 2020.&#13;
Methods:- A hospital-based cross-sectional study was conducted from September 1 to&#13;
December 30, 2020, in three selected public hospitals. A total of three hundred twenty&#13;
diabetic patients, selected by the consecutive sampling method. Socio-demographic, clinical,&#13;
lifestyle characteristics were collected with a structured questionnaire, data regarding&#13;
erectile function using the International Index of Erectile Function-5. Moreover, fasting&#13;
blood glucose and lipid levels were measured by A25 BioSystems clinical chemistry analyzer.&#13;
The data were entered and analyzed using the Statistical Package for Social Sciences-20.&#13;
Logistic regression was applied to identify an association between explanatory variables and&#13;
the outcome variable. An adjusted odds ratio with a 95% confidence interval and p-value less&#13;
than 0.05 was computed to determine the level of significance.&#13;
Results:- Out of 320 study participants,233(72.8%) had erectile dysfunction. Multivariate&#13;
analysis confirmed that age group of 40-49 years (Adjusted Odds Ratio [AOR]= 5.913,&#13;
95%CI:2.086-16.760), alcohol consumption (AOR=3.78495,95%CI:1.884-7.60), chat&#13;
chewing (AOR=2.440,95%CI:1.281-4.64),antihypertensive drug(AOR= 5.716 95%,CI:1.566&#13;
20.859),abnormal high density lipoprotein(AOR=2.371,95%CI:1.230-4.57),high total&#13;
cholesterol(AOR=2.971,95%CI;1.329-6.645), poor glycemic control (AOR =2.676; 95%&#13;
CI:1.405–5.098) were a significant predictor for erectile dysfunction.&#13;
Conclusion and recommendation: This study confirms the high prevalence of erectile&#13;
dysfunction in diabetic male patients in study settings. Thus, clinicians need to consider&#13;
preventive measures along with working on the downregulation of the offending agent of&#13;
patients in the study area. However; the authors also believe that there is a need for further&#13;
community based and case control studies on the current topic
</summary>
<dc:date>2021-03-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Computer-Aided Drug Discovery Strategies Targeting Plasmodium Falciparum Survival Proteins Pflipl2 and Pflpl3: Novel Inhibitor Identification and Validation via Alphafold2 Models</title>
<link href="https://repository.ju.edu.et//handle/123456789/10158" rel="alternate"/>
<author>
<name>Segni Megersa</name>
</author>
<author>
<name>James Wasmuth</name>
</author>
<author>
<name>Teshome Degefa</name>
</author>
<author>
<name>Ahmed Zeynudin</name>
</author>
<id>https://repository.ju.edu.et//handle/123456789/10158</id>
<updated>2026-02-26T08:59:14Z</updated>
<published>2025-08-11T00:00:00Z</published>
<summary type="text">Computer-Aided Drug Discovery Strategies Targeting Plasmodium Falciparum Survival Proteins Pflipl2 and Pflpl3: Novel Inhibitor Identification and Validation via Alphafold2 Models
Segni Megersa; James Wasmuth; Teshome Degefa; Ahmed Zeynudin
Background: Malaria, caused by Plasmodium falciparum, is the primary cause of severe &#13;
malaria and poses a global health challenge. Despite prevention and control strategies, the &#13;
increase in disease burden, drug resistance, life and economic loss necessitates novel therapeutic &#13;
strategies. In this study, we employed computer-aided drug discovery (CADD) to identify &#13;
inhibitors targeting two vital P. falciparum proteins, lipoate protein ligase-2 (PfLipL2) and &#13;
lysophospholipase (PfLPL3), using AlphaFold-predicted structures.  &#13;
Objectives: The general objective of the study was to leverage computational methods (virtual &#13;
screening, docking, consensus ranking and residue interaction analysis) to identify and validate &#13;
candidate antimalarial compounds targeting vital P. falciparum proteins from January to 2024 to &#13;
June 2025. &#13;
Methods and Materials: An AlphaFold‟s built in and Ramachandran plot was used for the 3D &#13;
model‟s structure quality validation. Virtual screening was carried out with MTiOpenScreen &#13;
server against protein targets and ADME properties were analyzed by SwissADME. Docking &#13;
was carried out using SwissDock and PyRx and ECR for prioritized candidates. Finally, &#13;
Discovery studio was used for protein-ligand‟s pose analysis. &#13;
Results: The 3D models had high structure quality. We screened 14,346 ligands, assessed &#13;
ADME properties, and docked 68 Lipinski-compliant ligands. Top three (10%) of prioritized &#13;
ligands ZINC000000537750, ZINC000001846243 and ZINC000030691430 for PfLipL2, and &#13;
ZINC000043203317, ZINC000001481805 and ZINC000004098812 for PfLPL3 were identified. &#13;
We found one top-ranked ligand with confirmed antimalarial activity against each target in &#13;
PubChem.  &#13;
Conclusions and Recommendation: The novelty of this work stems from its methodological &#13;
synergies: dual-tool docking for enhanced reliability and ECR-augmented prioritization for &#13;
superior ranking fostering greater confidence in hit selection. These results nominate promising &#13;
candidates for future experimental validation toward new antimalarial.
</summary>
<dc:date>2025-08-11T00:00:00Z</dc:date>
</entry>
</feed>
